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1. Introduction 
Nanomaterials are widely used for biomedical applications as their sizes are comparable 
with most of the biological entities. Many diagnostic and therapeutic techniques based on 
nanoscience and nanotechnologies are already in the clinical trial stages, and encouraging 
results have been reported. The progress in nanoscience and nanotechnology has led to the 
formation and development of a new field, nanomedicine, which is generally defined as the 
biomedical applications of nanoscience and nanotechnology. Nanomedicine stands at the 
boundaries between physical, chemical, biological and medical sciences, and the advances in 
nanomedicine have made it possible to analyze and treat biological systems at the cell and 
sub-cell levels, providing revolutionary approaches for the diagnosis, prevention and 
treatment of some fatal diseases, such as cancer. Nanomagnetism is at the forefront of 
nanoscience and nanotechnology, and in the field of nanomedicine, magnetic nanomaterials 
are among the most promising for clinical diagnostic and therapeutic applications. Similarly, 
luminescent materials are equally important for tagging and imaging applications. 
The nanomaterials used for biomedical purposes generally include zero-dimensional 
nanoparticles, one-dimensional nanowires and nanotubes, and two-dimensional thin films. 
For example, magnetic nanoparticles and nanotubes are widely used for labeling and 
manipulating biomolecules, targeting drugs and genes, magnetic resonance imaging (MRI), as 
well as hyperthermia treatment. Magnetic thin films are often used in the development of 
nanosensors and nanosystems for analyzing biomolecules and diagnosing diseases. As the 
synthesis and characterization of these nanostructures are completely interdisciplinary, there is 
a need of coordinated efforts for the successful implementation of these nanomaterials. The 
synthesis of nanoparticles with required shape, size, and core-shell configuration (surface 
coating) along with proper characterization are still in the early stage of research. On the other 
hand, due to the similar size to biological systems, nanoparticles pose potential threats to 
health and they could consequently have a large impact on industry and society. Hence, apart 
from successful synthesis and characterization of various nanomaterials, an effort to 
understand the toxicological impacts of nanomaterials much research has to be done to 
establish standards and protocols for the safe use of nanomaterials in industry as well as in the 
public arena, including academia and research laboratories. 
Nanoparticles have sparked intense interest in anticipation that this unexplored range of 
material dimensions will yield size-dependent properties. The physical and chemical 
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properties vary drastically with size and use of ultra fine particles clearly represents a fertile 
field for materials research. The modern biology and biomedical science have stepped into 
the molecular level. Effectively probing biological entities and monitoring their biological 
processes are still a challenge for both basic science investigation and practical 
diagnostic/therapeutic purposes. Since nanomaterials possessing analogous dimensions to 
those of functional aggregates organized from biomolecules they are believed to be a 
promising candidate interface owing to their enhanced interaction with biological entities at 
the nano scale (Whitesides, 2003). For this reason, nanocrystals with advanced magnetic or 
optical properties have been actively pursued for potential biomedical applications, 
including integrated imaging, diagnosis, drug delivery and therapy (Lewin et al., 2000; 
Hirsch et. al., 2003; Alivisatos, 2004; Kim et. al., 2004; Liao and Hafner, 2005). The 
development of novel biomedical technologies involving in vivo use of nanoparticles present 
multidisciplinary attempts to overcome the major chemotherapeutic drawback related to its 
spatial nonspecificity. For example, in most biomedical and magnetofluidic applications, 
magnetic nanoparticles of fairly uniform size and Curie temperature above room 
temperature are required.  On the other hand, as the major advantage of nanotubes, the 
inner surface and outer surface of nanotubes can be modified differently due to their multi-
functionalization. While the inner surface was tailored for better encapsulation of proper 
drugs, the outer surface can be adjusted for targeted accessing. On the other hand, the 
strong magnetic behavior made maghemite nanotubes easier controlled by a magnetic field, 
especially compared with hematite nanotubes. Mainly due to their tubular structure and 
magnetism, magnetic nanotubes are among the most promising candidates of 
multifunctional nanomaterials for clinical diagnostic and therapeutic applications. The 
tubular structure of magnetic nanotubes provides an obvious advantage as their distinctive 
inner and outer surfaces can be differently functionalized, and the magnetic properties of 
magnetic nanotubes can be used to facilitate and enhance the bio-interactions between the 
magnetic nanotubes and their biological targets (Son et. al., 2009; Liu et. al., 2009). One 
application paradigm of magnetic nanotubes is drug and gene delivery (Plank et. al., 2003). 
One of the major applications of magnetic nanomaterials is targeted drug delivery. In 
chemotherapies, to improve the treatment efficiency and decrease or eliminate the adverse 
effects on the healthy tissues in the vicinity of a tumor, it is practically desirable to reduce or 
eliminate undesirable drug release before reaching the target site, and it is really critical that 
the drugs are released truly after reaching the target site, in a controllable manner via 
external stimuli (Satarkar & Hilt, 2008; Chertok et. al., 2008; Hu et. al., 2008; Liu et. al., 2009). 
This remains one of the important fields of research for the development of smart drug 
carriers, whose drug release profiles can be controlled by external magnetic fields, for 
example the drug to be released is enclosed in a magnetic-sensitive composite shell.  
With rapid development of nanotechnology and handling of nanoparticles in various 
industrial and research and medical laboratories, it is expected that the number of people 
handling nanoparticles could double in few years from now putting more urge towards its 
safe use (Tsuji et. al. 2005). However, knowing the potential use and burden of exposure, 
there is little evidence to suggest that the exposure of workers from the production of 
nanoparticles has been adequately assessed (Shvedova et. al., 2003; Tsuji et. al. 2005). 
Despite these impressive, futuristic, possibilities, one must be attentive to unanticipated 
environmental and health hazards. In view of the above, the exposure to nanoparticles and 
nanotubes could trigger serious effects including death, if proper safety measures are not 
taken. Few findings from published articles certainly justify a moratorium on research 
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involving nanoparticles, if not all nanoparticles, until proper safeguards can be put in place, 
moreover safety tests need to be carried out keeping in view the type of nanomaterials 
present. Currently, the literature surveys on suggested nanotoxicity are few to draw any 
conclusion on the exposure dose of nanoparticles required for toxicity. 
2. Eu3+ doped Gd2O3 luminescent nanostructures  
The nanoscale structures, which include nanoparticles, nanorods, nanowires, nanotubes and 
nanobelts (He et. al., 2003; Chang et. al., 2005; Li et. al., 2007; Mao, et. al., 2008; Zhang et al., 
2009), have been considerably investigated due to their unique optical, electronic properties 
and prospective application in diverse fields, such as high quality luminescent devices, 
catalysts, sensors, biological labeling and other new functional optoelectronic devices. The 
precise architectural manipulation of nanomaterials with well-defined morphologies and 
accurately tunable sizes remains a research focus and a challenging issue due to the fact that 
the properties of the materials closely interrelate with geometrical factors such as shape, 
dimensionality, and size. The properties and performances of nanostructures strongly 
depend on their dimensions, size, and morphologies (Liu et. al., 2007). Therefore, synthesis, 
growth, and control of morphology in the crystallization process of nanostructures are of 
critical importance for the development of novel technologies.  
Rare earth doped oxides are promising new class of luminescent material due to their 
electronic and optical properties that arises from their 4f electrons. Therefore, much 
attention has been paid to their luminescent characteristics such as their large stokes shift, 
sharp emission visible spectra, long fluorescence lifetime (1-2 ms), and lack of photo-
bleaching compared with dyes (Wang et. al., 2005; Nichkova et. al., 2006). These materials, 
especially in the nanostructure, have been widely used in the lighting industry and 
biotechnology, including plasma display panel, magnetic resonance imaging enhancement, 
and microarray immunoassays for fluorescence labels (Seo et. al., 2002; Nichkova et. al., 
2005; Bridot et. al., 2007; Petoral et. al., 2009). Since the morphology and dimensionality of 
nanostructures are of vital factors, which particularly have an effect on the physical, 
chemical, optical, and electronic properties of materials,  it is expected that rare earth doped 
oxides synthesized in the form of nanoscale may take on novel spectroscopic properties of 
both dimension controlled and modified ion-phonon confinement effect compared to their 
bulk counterparts. Gd2O3, as a rare earth oxide, is a useful paramagnetic material and good 
luminescent rare earth doped host. Eu3+ ions can be doped into Gd2O3 easily since they are 
all trivalent ions and have the same crystal structure. Furthermore, 5D0 -7F2 of Eu3+ 
transitions exhibit red characteristic luminescence at a wavelength of 611 nm. Therefore, 
lanthanide oxide doped nanostructures can be used as electrical, magnetic or optical 
multifunction materials. 
Recently, considerable efforts have been made to synthesize low dimensional 
nanostructures (Chang et. al., 2005; Li et. al., 2007; Liu et. al., 2008). However, these 
processes have to be involved in hydrothermal routine, template, and catalysts. The 
nanostructure formed depends somehow on the pressure, template, and catalysts. This 
results in experimental complexity, impurities, defects and high cost. In addition, these 
methods especially could not meet large scale produce in industry. Therefore, it is necessary 
to find new methods to synthesize shape, size, and dimensionality controlled lanthanide 
doped oxides. On the other hand, because of the distinct low effective density, high specific 
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surface area, and encapsulation ability in hollow nanotubes these nanostructures are 
exceptionally promising in various fields such as confined catalysis, biotechnology, photonic 
devices, and electrochemical cells (Xu & Asher, 2004; Lou et. al., 2006; Wei et. al., 2008).  
Although lanthanide oxides are excellent host lattices for the luminescence of various 
optically active lanthanide ions (Mao et. al., 2009), Gd2O3 is a promising host matrix for 
down- and up conversion luminescence because of its good chemical durability, thermal 
stability, and low phonon energy (Yang et. al., 2007;  Jia et. al., 2009). 
3. Synthesis of Gd2O3: Eu+3 nanostructures 
Gd2O3 doped with Eu3+ nanostructures were synthesized by either sol-gel or co-
precipitation wet chemical solution methods. Nanoparticles were synthesized by a sol-gel 
method from their acetate hydrate precursors, which were dissolved in water. This solution 
was mixed with citric acid solution in 1:1 volume ratio ultrasonically for about 30 min. The 
mixture was heated in a water bath at 80 °C until all water is evaporated, yielding a 
yellowish transparent gel. The gel was further heated in an oven at 100 °C which formed a 
foamy precursor. This precursor decomposed to give brown-colored flakes of extremely fine 
particle size on further heating at 400 °C for 4 h. The flakes were ground and sintered at 800 
°C for duration of 2 h. Further heating in O2 ambient removed the carbon content.  
The nanoparticles of Eu:Gd2O3 were coated by adopting a base-catalyzed sol-gel process. 
100 mg of Eu:Gd2O3 were dispersed in 20 ml of 2-propanol solution and sonicated for 30 
min. 75 µl of tetraethoxysilane (TEOS) and 25 µL of 25% NH3H2O solution were injected into 
the above mixture and sonicated for 30 min at 60 ºC. By means of centrifugation the 
suspended silica capsulated Eu:Gd2O3 were obtained. The coated particles were washed 
several times by using acetone and methanol in order to remove any excess unreacted 
chemicals. The purified powder was naturally dried. This procedure produces a very 
uniform SiO2 coating, as determined using a transmission electron microscope (TEM). By 
changing the formulation of the coating solution, we can control the coating thickness. 
In the co-precipitation method, 0.5 M aqueous solution was prepared by dissolving 
Gd(NO3)3  and Eu(NO3)3 in deionized H2O. The nitrate solutions with cationic molar ratio of 
Gd to Eu is 0.95: 0.05 were mixed together and stirred for 30 minutes. The aqueous solution 
of 0.2 M NH4HCO3 was prepared and mixed with the nitrate solution drop wise while 
stirring to form the precipitate. It is noted that in this experiment extra 10 mol% NH4HCO3 
was added in order to ensure all the rare earth ions reacted completely to obtain rare earth 
carbonates. The white precipitate slurry obtained was aged for 24 hours at room 
temperature with continuous stirring. Then the precipitates were centrifugated and washed 
with deionized water for 5 times in order to completely remove NO3-, NH4+ and HCO3- 
followed by  drying at about 75 oC  in the stove. After drying, the white precursor was 
ground several times. It is noted that the dried precursor powders were very loosely 
agglomerated and can be pulverized very easily. To get Gd2O3 doped with Eu3+ 
nanostructures, the as-synthesized samples were further calcined at 600, 800, and 1000 oC in 
air for 2 hours in the furnace, respectively.  
Eu3+ doped Gd2O3 nanotubes were synthesized according to a modified wet chemical 
method (He et. al., 2003). A mixture of 30 ml of 0.08 M Gd(NO3)3 and Eu(NO3)3 with a 
nominal molar ratio of Eu/Gd 5 atom %,  in a form of clear solution, were added into flasks 
through ultrasound for 10 min. 30 ml of 25 wt % of ammonia solution was added quickly 
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into the solution under vigorous stirring for 20 min. Meanwhile, the pH value of the mixture 
was measured which came to a value of about 10. The mixture was heated under vigorous 
stirring in a 70 oC silicon oil bath for 16 hours. After this procedure, a white precipitate 
precursor was obtained. The final as-prepared precipitates were separated by centrifugation, 
washed with deionized water and ethanol for 4 times, respectively, and dried for 12 hours at 
65 oC in air to get as-grown sample. To get Gd2O3 product, the as-synthesized samples were 
further annealed in air for 2 hours at 600 oC in the furnace.  
Figure 1 (a-c) shows the representative TEM morphologies of Eu:Gd2O3 nanoparticles. The 
size distribution is rather narrow, and the nanocrytallite size is in the range of 20-30 nm for 
as-prepared nanoparticles by citric-gel technique. However, the nanoparticles are slightly 
agglomerated. The particle sizes increase to 30-40 nm if the nanoparticles are calcined up to 
800 oC. Figure 1 (c) represents the TEM image of Eu:Gd2O3 nanoparticle coated by SiO2 
indicating distinctly well dispersed nanoparticles. It is noted that the size of the SiO2 shell 
can be controlled by controlling TEOS and NH3H2O solution. 
 
 
Fig. 1. Transmission electron microscopy (TEM) image of Eu:Gd2O3 nanopowders of (a) as 
prepared, (b) calcined at 800 oC and (c) SiO2 coated. 
Figure 2 shows the emission spectra of citric-gel technique synthesized Eu doped Gd2O3 
nanoparticles. The photoluminescence spectrum illustrates the Eu3+ ions are in cubic 
symmetry and indicate the characteristics of red luminescent Eu:Gd2O3, in which the 
5D0→7F2 transition at about 611 nm is prominent, and the relatively weak emissions at the 
shorter wavelengths are due to the 5D0→ 7F1 transitions. The cubic structure provides two 
sites, C2 and S6, from two different crystalline sites, in which the 5D0→7F2 transition 
originates from the C2 site of the electric dipole moment of Eu3+ ions that scarcely arises for 
the S6 site because of the strict inversion symmetry. This suggests that the emission emerges 
mainly from the C2 site in the cubic structure. The emission spectra show similar 
characteristics after SiO2 coating on the surface of Eu:Gd2O3 nanoparticles. This clearly 
suggests that the emission properties of Eu ions remain intact even after SiO2 coating, and 
can be utilized for biomedical tagging. 
Figure 3 shows the magnetic moment of Eu:Gd2O3 and SiO2 coated Eu:Gd2O3 nanoparticles 
at 300 K. Both nanoparticles demonstrate paramagnetic behavior at room temperature. On 
the other hand, the coated nanoparticles showed reduced magnetization compared to 
Eu:Gd2O3 due to reduction in the volume fraction caused by SiO2 coating.  
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Fig. 2. Photoluminescence of Eu:Gd2O3 nanoparticles calcined at 800 0C. 
 
 
Fig. 3. Magnetic moment of Eu:Gd2O3 and SiO2 coated Eu:Gd2O3 nanoparticles. 
The morphology of Eu3+ doped Gd2O3 nanorods obtained after calcination at 600 oC for 2 
hours strongly depends on the heat treatment temperature. The formation of nanorods with 
low aspect ratio is preferred at 600 oC. It can be seen from the micrograph that all the 
nanorods display uniform morphology having size of 10 nm in diameter and more than 300 
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nm in length (Figure 4(a)). In contrast, the nanorods grow bigger in diameter (about 25 nm) 
and shorter in length (about 100 nm) after the heat treatment at 800 oC as shown in Figure 
4(c). However, it is evident that Eu3+ doped Gd2O3 nanorods maintain the anisotropic shape 
during heat treatment from 600 oC to 800 oC. It can also be observed that the formation of 
nanorods is related to the fact that the growth direction are preferred along the [211] 
crystallographic orientation. This is because the spacing between fringes along nanorod axes 
is about 0.40 nm which is close to the interplanar distance of the cubic (211) plane as shown 
in Figure 4 (b) and (d). Figure 4(e) presents the TEM images of Eu3+ doped Gd2O3 
nanoparticles with size of 60 nm in diameter obtained by heat treatment at 1000 oC. The 
morphology of Eu3+ doped Gd2O3 nanostructure dependent on the heat treatment 
temperature is possibly attributed to meta-stable states which are able to recrystallize at 
1000 oC. A favorable growth pattern parallel to the (222) plain corresponding to interplanar 
spacing of 0.3 nm dominates the recrystallization of nanorods and transFigures to form 
nanoparticles as shown in Figure 4(f). 
 
 
 
Fig. 4. Eu3+ doped Gd2O3 nanostructures TEM photographs of low and high magnification 
after annealing at (a) and (b) 600 oC, (c) and (d) 800 oC,  and (e) and (f) 1000 oC, 
respectively.(b), (d) and (f) represent the HR-TEM images of respective nanostructures. 
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The optical properties and characteristics of nanostructures used in the photonic application 
are typically determined by their dimensions, size, and morphologies. The intensity of 
photoluminescence of Eu3+ doped Gd2O3 nanorods strongly depends on the annealing 
temperature at which the morphology of nanostructures gets modified. Figure 5 shows the 
emission spectra of Eu3+ doped Gd2O3 nanorods excited by 263 nm ultraviolet light.  
 
 
Fig. 5. Photoluminescence spectra of Eu3+ doped Gd2O3 nanostructures annealing at 600 oC, 
800 oC, and 1000 oC, respectively. 
The emission spectra exhibit a strong red emission characteristic of the 5D0-7F2 (around 613 
nm) transition which is an electric-dipole-allowed transition. The weaker band around 581 
nm, 589 nm, 593 nm, 600 nm and 630 nm are ascribed to 5D0-7F1, 5D1-7F2, 5D0-7F0, 5D0-7F1, and 
5D0-7F2, respectively (Liu et. al., 2008). The emission spectra indicates that the Eu3+ doped 
Gd2O3 nanostructures represent  strong, narrow, and sharp emission peaks. As shown in 
Figure 5, the intensity of emission at 613 nm of nanorods increases when the annealing 
temperature increases from 600 oC to 800 oC modifying the morphology of the nanorods as 
described earlier. However, when the annealing temperature reaches 1000 oC, the emission 
intensity is reduced significantly, even less than the one annealed at 600 oC. The 
performance change of photoluminescence in these nanostructures can be attributed to the 
morphological transformation of the nanostructures as described below. At low annealing 
temperature, the Eu3+ doped Gd2O3 exhibits nanorod morphology with more surface area 
containing a larger number of luminescent centers. However, when the temperature was 
increased to 1000 oC, the nanorods transformed to nanoparticles which have more surface 
area altogether. This increase in surface area resulted in more defects, especially surface 
defects and strains, located on the surface of the nanoparticles. Although high annealing 
temperature can increase crystal perfection, the defects on the surface of these nanoparticles 
can overwhelm, causing reduced photoluminescence.  
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In order to systematically investigate the correlation of morphology and optical 
characteristics of Eu3+ doped Gd2O3 samples, the 5 at.% Eu3+ doped Gd2O3 nanorods 
fabricated at 600 oC were used. Representative TEM and SEM images of Eu3+ doped Gd2O3 
nanotubes are shown in Figure 6. It can be observed these nanostructures demonstrate 
tubular shape with a length in the range about 0.7-1 μm and the wall thickness of 20 nm. It 
also reveals that these one dimension nanostructures have open ends, smooth surface and 
straight morphology as shown in Figure 6 (a) and (b). Figure 6(c) demonstrates the Field 
Emission-Scanning Microscope (FE-SEM) image large number of uniform nanotubes. The 
open end and the associated fine feature, such as uniform size and shape, of these nanotubes 
are shown in the inset of Figure 6.  
 
 
 
 
Fig. 6. (a) and (b)  Low magnification TEM photographs and (c) FE-SEM images of Eu3+ 
doped Gd2O3 nanotubes after annealing at 600 oC. The inset in (c) demonstrates the 
nanotube feature of Eu3+ doped Gd2O3. 
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It is obviously revealed that the emission intensity of nanotubes is larger than the nanorods 
of Eu3+ doped Gd2O3 samples as shown in Figure 7. Nanotubes have more surface area than 
the nanorods. It is worth mentioning that the emission measurements were performed with 
a very similar conditions and volume fractions of nanomaterials used in this study. 
Although, the number of defects increases with the increase of area in nanotubes, the layer 
surface area overwhelms the luminescent intensity.  
 
 
Fig. 7. Photoluminescence spectra comparison of Eu3+ doped Gd2O3 nanotubes (a) and 
nanorods (b) annealed at 600 oC, respectively. 
4. ZnO nanostructures 
Zinc oxide (ZnO) is a semiconductor material with various configurations, much richer than 
of any other known nanomaterial (Pradhan et. al., 2006; Ma et. al., 2007). At nanoscale, it 
posses unique electronic and optoelectronic properties and finds application as biosensors, 
sunscreens, as well as in medical applications like dental filling materials and wound 
healing (Ghoshal et. al., 2006). Because of the indiscriminate use of ZnO nanoparticles, it is 
important to look at their biocompatibility with biological system. A recent study on ZnO 
reports that it induces much greater cytotoxicity than non-metal nanoparticles on primary 
mouse embryo fibroblast cells (Yang et. al., 2009), and induces apoptosis in neural stem cell 
(Deng et. al., 2009). Published reports have shown that ZnO inhibits the seed germination 
and root growth (Lin & Xing, 2007); exhibit antibacterial properties towards Bacillus subtilis 
and to a lesser extent to Escherichia coli (Adams et. al., 2006). Inhalation of ZnO compromises 
pulmonary function in pigs and causes pulmonary impairment and metal fume fever in 
humans (Fine et. al., 1997; Beckett et. al., 2005). Literature evidences showed that ZnO 
nanoparticles are the most toxic nanoparticle with the lowest LD50 value among the 
engineered metal oxide nanoparticles (Hu et. al., 2009). On the other hand, it was also 
reported that zinc oxide was not found to be cytotoxic to cultured human dermal fibroblasts 
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(Zaveri et. al., 2009). In recent years, there has been an escalation in the development of 
techniques for synthesis of nanorods and subsequent surface functionalization. ZnO 
nanorods exhibit characteristic electronic, optical, and catalytic properties significantly 
different from other nano metals. Keeping in view of the unique properties and the 
extensive use of ZnO in many fields and also contradictory results on ZnO toxicity from 
both in-vitro and in-vivo studies, we report here to synthesize and characterize the ZnO 
nanorods on hela cells for its biocompatibility/toxicity. 
5. Synthesis: ZnO nanotubes  
The typical method employed is as follows. Equal volume of 0.1 M aqueous Zinc acetate 
anhydrous and Hexamethylenetetramine were mixed in a beaker using ultrasonication for 
30 min. After the mixture was mixed well, it was heated at 80 °C in water bath for 75 min, 
during which white precipitates were deposited at the bottom. Then it was incubated for 30 
min in ice cold water to terminate the reaction. The product was washed several times (till 
the pH of solution becomes neutral) using the centrifuge with deionized water and alcohol, 
alternatively to remove any by-product and excess of hexamethyleneteteamine.  After 
washing, the solution was centrifuged at 10,000 rpm (12,000×g) for 20 min and the settled 
ZnO was dried at 80 ◦C for 2 h.  
Fig. 8 (a, b) shows the SEM micrograph collected on synthesized ZnO nanorods surface 
morphology. The nanorod was grown perpendicular to the long-axis of the matrix rod and 
grew along the [001] direction, which is the nature of ZnO growth. The morphology of ZnO 
nanorod was further confirmed by the TEM image as shown in Fig. 8 (c, d). Though the rod 
cores were monodisperse, the length of the nanorod was estimated to be around 21 nm in 
diameter and the length around 50 nm. 
 
 
Fig. 8. (a and b) Scanning electron micrograph of ZnO nanorods. (c and d) Transmission 
electron micrograph of ZnO nanorods. 
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6. Toxicity studies: Eu:Gd2O3 nanoparticles 
For cell culture and treatments, rat lung epithelial cell line (LE, RL 65, ATCC; CRL- 10354) 
from ATTC was grown at 37 °C in an atmosphere of 5% CO2 and in complete growth 
medium supplemented with 1% penicillin/streptomycin and 10% fetal bovine serum (FBS). 
Eu:Gd2O3 were suspended in Dimethyl formamide (DMF) and sonicated for 5 minutes and 
henceforth in all control experiments the cells were treated with equivalent volume of DMF. 
The cells were incubated with or without nanoparticles in 96 well plates for time intervals as 
indicated in the respective Figure legends. 
The measurements of intracellular reactive oxygen species (ROS) were performed in the 
following way. Oxygen radicals collectively called as reactive oxygen species play a key role 
in cytotoxicity. Increased ROS levels in cells by chemical compounds reflect toxicity and cell 
death. To study the induction of oxidative stress in LE cells, 1x104 cells/well were seeded in 
96 well plate and grown overnight under standard culture conditions. The cells were then 
treated with 10 µM of dichlorofluorescein [5-(and-6)-carboxy-2,7`-dichloro-
dihydroxyfluorescein diacetate, H2DCFDA, (C-400, Molecular Probes, Eugene, OR) for 3 h in 
Hank’s balanced salt solution (HBSS) in incubator. Following 3 h of incubation, cells were 
washed with phosphate buffered saline (PBS) and treated with different concentrations of 
Eu:Gd2O3 nanoparticles. Following incubation the intensity of fluorescence is measured at 
different time intervals at excitation and emission of wavelength at 485/527 nm, 
respectively and expressed as fluorescence units.  
LE cells were seeded at 5x103 cells/well in a 96 well plate and allowed to grow overnight. 
After 18 h in serum-free medium, cells were treated with different concentrations of 
nanoparticles and grown for 72 h. At the end of the incubation, cells were additionally 
treated with 3-[4, 5-dimethylthiazol- 2-yl]-2,5-diphenyltetrazolium bromide] MTT for 3 h. 
The cells were then washed with chilled PBS and formazon formed was solubilized in 100 
µL of acidic propanol and the absorbance was read at 570 nm. 
The results of the toxicity test are presented in Fig. 9. The cytotoxicity assay was 
essentially performed as described elsewhere (Zveri et. al., 2009). Figure 9 indicates the 
effect of coated and uncoated Eu:Gd2O3 on rat LE cells suggesting that they induce ROS in 
a dose dependent manner. Uncoated Eu:Gd2O3 increased ROS by 0.5 folds as compared to 
control at a concentration as low as 2.5 µg were as coated Eu:Gd2O3  showed 1 fold  
increase in ROS. Coated and uncoated Eu:Gd2O3 induces very less ROS. To study the 
extent of damage caused by coated and uncoated Eu:Gd2O3 on cell viability, MTT assay 
was carried in LE cells treated with various concentrations and  the results suggest that 
the cell viability decreases with increase in concentration of nanoparticles by 72 hrs 
compared to control.  It was found that 60% of cells found to be viable at 2.5µg/ml of 
uncoated Eu:Gd2O3  where as 50% found to be viable with cells treated with coated 
Eu:Gd2O3. In all, measurement of intracellular reactive oxygen species and MTT assay 
results show that Eu:Gd2O3 nanoparticles are relatively nontoxic and the toxicity is further 
decreased on SiO2 coating (Zhang et. al., 2009). 
7. Toxicity studies of ZnO nanorods 
Hela cells, which are immortalized cervical cancer cells, are used for the testing of ZnO 
nanorods. Hela cells were treated with different concentration (0.5, 1.0, 2.0, 2.5, 5.0,10 
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μg/ml) of ZnO nanorods for 3 h. They showed no significant induction of ROS (Fig. 10 a). 
Earlier studies on different nanoparticles such as single and multi walled carbon nanotubes 
showed significantly increased levels of ROS at 5-10μg/ml (Manna et. al., 2005; Sarkar et. al., 
2007; Ravichandran et. al., 2009), whereas no increase in ROS level even in 20μg/ml was 
detected in ZnO nanorods. The time kinetics was also performed to check the formation of 
ROS (Fig. 10 b). It is seen that there is no significant ROS level formed as early as 30 min 
with 10μg/ml of ZnO nanorods and remained same till 150 min is passed. However, at later 
time intervals the increase in ROS was observed in 10μg/ml but very less as compared to 
the control. This may be due to osmotic pressure created by excess of nanorods. Next, the 
level of lipid peroxidation in ZnO nanorods exposed hela cells was investigated. This is 
another possible player for oxidative stress induction. It was observed that very minimal (as 
low as 0.1 fold) increase in lipid peroxidation level with 10μg/ml of ZnO nanorods as 
compared to the control.  
 
 
 
Fig. 9. (a) Uncoated (left) and coated (right) Eu:Gd2O3 induces ROS in rat LE cells, and (b) 
MTT assay effect of uncoated (left) and coated (right) Eu:Gd2O3 on cell viability. 
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Fig. 10. Effect of ZnO nanorods on oxidative stress. Equal numbers of 1×105 hela cells/well 
were grown for 18 h. (a) The grown cells were incubated with 10 μM of DCF for 3 h, treated 
with different concentration of ZnO nanorods. Fluorescence was measured at excitation and 
emission wavelengths of 485 and 527 nm, respectively, at the end of 3 h. (b) Time kinetics of 
ROS formation by ZnO nanorods. Overnight grown hela cells were treated with 1, 5, and 10 
μg/ml of ZnO nanorods. Fluorescence was measured at excitation and emission 
wavelengths of 485 and 527 nm, respectively, at different time points. The values are 
expressed as DCF fluorescence units, mean ± SD of eight wells and the Figure is a 
representative of three experiments performed independently 
In order to check whether ZnO nanorod has any role on toxicity without altering oxidative 
stress, analysis of cell damage using MTT assay after exposing to various concentration of 
ZnO nanorods (0.5, 1.0, 2, 2.5, 5.0, 10 μg/ml) (Fig. 11a) was performed. The MTT assay 
showed no significant decrease in cell viability suggesting that ZnO nanorods did not have 
any effect on cell toxicity. More than 98% of cells were viable at concentration of 10 μg/ml 
ZnO nanorods which is also confirmed by live dead cell assay (Fig. 11b). 50% of cell death 
was observed in mouse neuroblastoma cells using 100 μg/ml of ZnO (Prasad et. al., 2006), 
whereas other reports have also shown 100% cytotoxicity at 15 μg/ml of ZnO on 
mesothelioma MSTO-211H or rodent 3T3 fibroblast cells (Brunner et. al., 2006), and 90% cell 
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death with 20mgL−1 of ZnO nanoparticles on HELF cells (Yuan et. al., 2010). Also, 5 mM of 
ZnO nanoparticle are shown to be less toxic to human T cells (Reddy et. al., 2007). Previous 
studies from our laboratory on hela cells and other cells such as lung epithelial, H1299, A549 
and HaCaT cells showed the decrease in cell viability at 5 μg/ml when they were exposed to 
SWCNT and MWCNT (Manna et. al., 2005; Sarkar et. al., 2007; Ravichandran et. al., 2009).  
Toxicological studies on hela cells and conclude that ZnO nanorods could be the safe 
nanomaterials (Gopikrishnan el. al., 2010) for biological applications. 
 
 
 
Fig. 11. Effect of ZnO nanorods on cell viability. HeLa cells (2000/well in a 96-well plate) 
were incubated for 12 h and treated with different concentration of ZnO nanorods for 72h. 
(a) Cell viability was assayed by MTT dye uptake. The mean absorbance at 570 nm is 
represented as cell viability percentage of the control and is mean ± SD of eight wells. (b) 
HeLa cells were treated with 5 μg/ ml and10 μg/ml of ZnO nanorods for 72 h and the dead 
cell (red color) numbers were counted. The percentage of dead cells is indicated below each 
photograph. 
8. Magnetic nanoparticles 
8.1 Synthesis: LaSrMnO nanoparticles 
La0.7Sr0.3MnO3 nanoparticles were synthesized by a sol-gel method from their acetate 
hydrate precursors, which were dissolved in water (Pradhan el. al., 2008; Zhang el. al., 2010). 
This solution was mixed with citric acid solution in 1:1 volume ratio ultrasonically for about 
30 min. The mixture was heated in a water bath at 80 °C until all water is evaporated, 
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yielding a yellowish transparent gel. The gel was further heated in an oven at 100 °C which 
formed a foamy precursor. This precursor was decomposed to give black-colored flakes of 
extremely fine particle size on further heating at 400 °C for 4 h. The flakes were ground and 
sintered at 800 °C for duration of 2 h. Further heating in O2 ambient removed the carbon 
content. The ball milling was used with methanol to reduce the size of nanoparticles of 
LSMO (Fig. 12). The solution containing suspended LSMO nanoparticles was separated 
using ultra-high centrifuge using methanol for several times. 
 
 
Fig. 12. FE-EM image of LSMO nanoparticles annealed at 800 oC, showing the individual 
nanoparticles. 
The nanoparticles of ball milled LSMO were coated by adopting a base-catalyzed sol-gel 
process. 100 mg of LSMO were dispersed in 20 ml of 2-propanol solution and sonicated for 
30 min and the nanoparticles were shown in Fig. 13 (a). 75 µl of TEOS and 25 µL of 25% 
NH3H2O solution were injected into the above mixture and sonicated for 30 min at 60 ºC. 
The suspended silica capsulated LSMO nanoparticles were obtained by means of 
centrifugation. The coated nanoparticles were washed several times by using acetone and 
methanol in order to remove any excess unreacted chemicals. The purified powder was 
naturally dried. This procedure produces a very uniform SiO2 coating, as determined using 
a transmission electron microscope. By changing the formulation of the coating solution, the 
coating thickness can be controlled. 
8.2 FeCo nanoparticles 
FeCo nanoparticles were synthesized by a coprecipitation method under Ar atmosphere 
from their chloride hydrate precursors. The FeCo nanopowders were dried in Ar gas, and 
were dispersed in 2- propanol solvent with 10-2 M and sonicated for 1 hour followed by 
addition of TEOS and 25% ammonia solution of volume ration 3:1. The mixture was 
sonicated for 1 h to coat the SiO2 onto the surface of FeCo nanoparticles. The solution 
containing suspended FeCo-SiO2 nanoparticles was decanted and purified using methanol 
several times in order to remove unreacted Fe and organic materials from the surface. The 
coated nanopowders were naturally dried in air. Figure 14 (a) shows XRD pattern of the as-
synthesized samples, indicating typical amorphous phase. The amorphous phase in FeCo 
nanoparticles is generated because the coprecipitation reaction takes place below the glass 
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transition temperature and boron atoms are presented in the nanoparticles. The solution 
containing suspended FeCo-SiO2 nanoparticles was decanted and purified using methanol 
several times in order to remove unreacted Fe and organic materials from the surface. The 
coated nanopowders were naturally dried in air.  
 
 
 
Fig. 13. (a) FE-SEM image of ball-milled LSMO nanopowder. (b) Temperature dependence 
of FC and ZFC magnetization of ballmilled and TEOS-coated nanoparticles. The inset shows 
the MH curve for ball-milled sample at 300 K. 
 
Fig. 14. (a) XRD patterns of FeCo nanoparticles prepared for 4 h, (b) FE-SEM and (c) TEM 
images of as synthesized FeCo nanoparticles, and (d) FeCo nanoparticles coated with silica. 
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Fig. 15. Magnetization hysteresis loops of FeCo nanoparticles synthesized at various 
conditions and FeCo nanoparticles coated with silica. 
Figure 14 (b) and (c) show the FE-SEM and TEM image of the uncoated FeCo nanoparticles, 
respectively. The FeCo nanoparticles are spherical in shape with about 20 nm in size and well-
dispersed. The size distribution is very uniform, indicating the high-quality of the 
nanoparticles. Figure 14 (d) shows the TEM image of the silica coated FeCo nanoparticles, 
exhibiting well-formed FeCo cores with SiO2 shell of couple of nm. It was realized that the 
shell diameter can be increased with increasing coating time, concentration and temperature. 
Figure 15 shows the magnetic hysteresis of FeCo nanoparticles. It is noted that the 
magnetization saturation moment increases when FeCo nanoparticles are synthesized at lower 
temperature (such as at ice temperature) due to controlled nucleation compared to as-grown 
nanoparticles. The magnetization of silica coated FeCo decreases, mainly due to the reduction 
in the demagnetization factor among nanoparticles through coupling, which is generally 
induced through direct exchange coupling and dipolar interaction. The magnetization 
reduction in coated FeCo is not significant, illustrating a strong dipolar exchange coupling. 
9. Toxicity of magnetic nanoparticles 
9.1 LSMO nanoparticles 
The effect of LSMO and silica-coated LSMO NPs on reactive oxygen species were measured 
by a real time assay. To study the induction of oxidative stress in lung epithelial (LE) cells, 
1x104 cells/well were seeded in 96 well plate and grown overnight under standard culture 
conditions. The cells were then treated with 10 µM of dichlorofluorescein [5-(and-6)-
carboxy-2, 7-dichloro-dihydroxyXuorescein diacetate, H2DCFDA, (C-400, Molecular Probes, 
Eugene, OR)] for 3 h in Hank’s balanced salt solution (HBSS) in incubator. Following 3 h of 
incubation, cells were washed with phosphate buffered saline (PBS) and 5 µg, 10 µg and 60 
µg of LSMO and Si coated-LSMO NPs was added respectively and incubated at 37 ºC. Cells 
were incubated in an incubator for 3 h as detailed in the Figure caption of Fig. 16, and 
fluorescence was measured at excitation wavelength of 485 nm and emission was recorded 
at 527 nm (Thermo Lab Systems, Franklin, MA). It is very clear from Fig. 16 that silica-
coated LSMO NPs generate less oxidative stress in LE cells compared to uncoated NPs. 
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Fig. 16. Effects of magnetic nanoparticles on time kinetics of ROS in LE cells. (a) LSMO 
generates oxidative stress in LE cells. 1x105 cells/well were seeded in a 96 well plate and 
grown at standard conditions for 24 h. Following overnight incubation, cells were starved in 
serum free medium for 24 h. Then cells were washed with phosphate buffered saline and 
incubated with 10 µM DCF for 3 h in HBSS. The cells were then treated with 5, 10 and 60 µg 
of LSMO. The change in DCF fluorescence was measured at 485 and 527 nm respectively 
after each time interval as shown. Values are mean ± SD of eight wells and are a 
representative from three experiments performed independently. (b) Silicon coated LSMO 
generates less oxidative stress in LE cells using the experiment described in (a). 
The cytotoxicity assay was essentially performed as described earlier. The LE cells were 
seeded at 5x103 cells/well in a 96 well plate and grown overnight. After 18 h in serum-free 
medium, cells were treated with different concentrations of LSMO and Si coated-LSMO and 
grown for 72 h. At the end of the incubation, cells were additionally treated with 3-[4, 5-
dimethylthiazol- 2-yl]-2,5-diphenyltetrazolium bromide] MTT for 3 h. The cells were then 
washed with chilled PBS and formazon formed was extracted in 150 µL of acidic methanol 
and the absorbance was read at 570 nM. Fig. 17 demonstrates that the silica-coated LSMO 
NPs have better cell viability compared to uncoated NPs. 
The above cytotoxicity tests (ROS and cell viability) demonstrate that LSMO nanoparticles 
can be potential candidate for various biomedical applications. Further perfection can be 
made achieved by coating the nanoparticles with silica in a controlled way. Apart from in 
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vivo biomedical applications, LSMO nanoparticles can also be utilized in protein purification 
due to their size-dependent magnetic properties, where large size (> 50 nm) NPs show 
strong ferromagnetic properties at room temperature. The LSMO nanoparticles may be 
complementary to paramagnetic nanoparticles composed of Ni and NiO (Rodríguez-
Llamazares et. al, 2008; Wong et. al., 2008).  The in situ modification of the surface during the 
precipitation (Wong et. al., 2008) used for LSMO nanoparticles becomes very effective in 
reducing the cytotoxicity. 
 
 
Fig. 17. Effect of magnetic nanoparticles on cell viability. (a) LSMO decreases cell viability in 
LE cells. 2000 cells/well were seeded in a 96 well and grown under standard condition for 
24 h. Following overnight incubation, cells were starved in serum free medium for 24 h. 
Cells were then treated with 0.5, 1, 5, 10, 20, 40, 60, 80 and 100 μg of LSMO and allowed to 
grow for 72 h. The MTT assay was then performed. The mean absorbance at 570 nm is 
represented as percent of control and is mean ± SD of eight wells. The values are a 
representative from three experiments performed independently. (b) Effect of silica-coated 
LSMO cell viability using the procedure described in (a). 
9.2 FeCo nanoparticles 
The result of the toxicity test is presented in Fig. 18. The effect of FeCo and silica-coated 
FeCo nanoparticles on rat LE cells suggests that they induce ROS in a dose dependent 
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manner. Uncoated FeCo nanoparticles increased ROS by 3.2 folds as compared to control at 
a concentration as low as 2.5 μg. The coated FeCo nanoparticles showed 3.6 fold increase in 
ROS (Fig. 18 (b)). To study the extent of damage caused by coated and uncoated FeCo on 
cell viability, MTT assay was carried in LE cells treated with various concentrations and the 
results suggest that the cell viability decrease with increase in concentration of FeCo 
nanoparticles by 72 hrs compared to control. Only 40% of cells found to be viable at 2.5 
μg/ml of uncoated FeCo, where as 35% found to be silica-coated FeCo nanoparticles. This 
suggests that the silica shell thickness should be increased in order to reduce the toxicity of 
FeCo nanoparticles for any biomedical applications. 
 
 
Fig. 18. MTT assay effect of (a) uncoated and (b) coated FeCo nanoparticles on cell viability. 
10. Conclusion 
Nanomaterials are widely used for biomedical applications because their sizes are 
comparable with most of the biological entities. The development of novel biomedical 
technologies involving in vivo use of nanoparticles presents multidisciplinary attempts to 
overcome the major chemotherapeutic drawbacks. Nanomaterials stand at the boundaries 
between physical, chemical, biological and medical sciences, and the advances in this field 
impact analyzing and treating biological systems at the cell and sub-cell levels, providing 
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revolutionary approaches for the diagnosis, prevention and treatment of some fatal diseases, 
such as cancer. However, the synthesis, characterization and use of these nanomaterials 
need thorough studies. The synthesis and characterization of several kinds of nanomaterials, 
such as luminescent, semiconducting and magnetic, are discussed. The toxicity associated 
with these nanomaterials is also discussed. 
Luminescent nanostructures. Eu3+ doped Gd2O3 nanomaterials are very promising 
luminescent as well as magnetic material. Some typical growth process for varieties of 
nanostructures, such as nanoparticles, nanorods, nanotubes and encapsulated nanoparticles, 
are described with some insight into their microstructures and their optical and magnetic 
properties. The toxicity studies of some of these nanostructures demonstrate that Eu:Gd2O3 
nanoparticles are relatively nontoxic and the toxicity is further decreased on silica coating. 
Semiconductor nanostructures. A typical chemical route was explored to synthesize large scale 
ZnO nanorods with about 21 nm in diameter and 50 nm in length. Toxicological studies on 
hela cells show that ZnO nanorods could be the safe nanomaterials for biological 
applications. 
Magnetic nanostructures. Manganites and FeCo nanoparticles were synthesized by the 
chemical technique and the nanostructures were coated with TEOS and other 
macromolecules. The manganites display essential magnetic properties applicable for 
hyperthermia applications. On the other hand, FeCo nanoparticles display strong 
magnetism appropriate for protein purification. 
 The cytotoxicity tests (ROS and cell viability) demonstrate that both manganites and FeCo 
nanoparticles can be potential candidate for various biomedical applications. Further 
perfection can be made achieved by coating the nanoparticles with silica in a controlled 
way. The silica shell thickness should be increased in order to reduce the toxicity of FeCo 
nanoparticles for any biomedical applications. 
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